Healthcare entity
Every one of those 2 sits in a single category, medical-devices. University of Sydney is most often covered alongside Cell Biomaterials, which appears in 1 of these 2 stories. Source depth averages 3 original sources per story, versus 2.3 across the same-window beat baseline.
Last mentioned: Jun 14, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 2 sits in a single category, medical-devices. University of Sydney is most often covered alongside Cell Biomaterials, which appears in 1 of these 2 stories. Source depth averages 3 original sources per story, versus 2.3 across the same-window beat baseline. Their average consequence score of 5.5 runs below the beat's 6.3 for that window. This profile follows 2 Healthcare stories mentioning University of Sydney across the period from July 25, 2026 to July 27, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 42 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering University of Sydney. Shared-story counts are live from our verified record — not editorial picks.
A student-led health initiative delivered 1,000 reusable menstrual cups to girls in rural Zambia, leading to measurable reductions in school absenteeism. The project combined product distribution with a culturally sensitive education campaign to overcome local taboos, demonstrating a scalable model for menstrual health management in low-resource settings.
A patient‑specific ‘artery‑on‑a‑chip’ that mimics a person’s carotid geometry and clotting behavior is set to revolutionize stroke risk prediction, especially for underserved populations. The technology, tested on six patients, could spare low‑risk individuals from unnecessary interventions while catching those at high risk. A clinical trial is now recruiting.
Source: elpasoinc.com · the-messenger.com
University of Sydney is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
